Reven Pharmaceuticals Stock

Bio-Pharmaceutical Company

Sign up today and learn more about Reven Pharmaceuticals Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Reven Pharmaceuticals Stock

Reven Holdings, Inc. is a development-stage bio-pharmaceutical company that develops and markets propriety solutions for the treatment of cardiovascular and metabolic related conditions.

Funding History

January 2014$1.8M
January 2014$5.0M
February 2015$4.4M
January 2016$10.0M
January 2017$23.0M
January 2019$23.0M


Co-Founder & Chief Executive Officer

Peter Lange

Chief Financial Officer

Jeffrey Halverson

Chief Technology Officer

James Ervin

Chief Operating Officer

Brian Denomme

Chief Medical Officer

Fatih Uckun


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: